AVNS vs EXPE · rev $687.8M vs P/E 20, rev $7.74B
Avanos Medical Inc (AVNS) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Avanos Medical Inc (AVNS) is a medical devices company listed on NYSE.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported AVNS revenue for 2024-12-31 was $687.8M. Net income was -$392.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. AVNS currently screens at market cap $1.17B.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
AVNS currently screens at market cap $1.17B. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the AVNS and EXPE stock pages for the full models.
Not investment advice.